Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)

Eduardo Rodríguez-Arbolí; Megan Othus; Sylvie D. Freeman; Francesco Buccisano; Lok Lam Ngai; Ian Thomas; Raffaele Palmieri; Jacqueline Cloos; Sean Johnson; Elisa Meddi; Nigel H. Russell; Adriano Venditti; Patrycja Gradowska; Gert J. Ossenkoppele; Bob Löwenberg; Roland B. Walter

doi:10.1038/s41375-024-02378-5

Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)

Eduardo Rodríguez-Arbolí, Megan Othus, Sylvie D. Freeman, Francesco Buccisano, Lok Lam Ngai, Ian Thomas, Raffaele Palmieri, Jacqueline Cloos, Sean Johnson, Elisa Meddi, Nigel H. Russell, Adriano Venditti, Patrycja Gradowska, Gert J. Ossenkoppele, Bob Löwenberg, Roland B. Walter^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2266-2269
Number of pages	4
Journal	Leukemia
Volume	38
Issue number	10
Early online date	21 Aug 2024
DOIs	https://doi.org/10.1038/s41375-024-02378-5
Publication status	Published - Oct 2024

Keywords

Humans
Neoplasm, Residual/diagnosis
Leukemia, Myeloid, Acute/pathology
Flow Cytometry/methods
Prognosis
Middle Aged
Male
Female
Aged
Adult

Access to Document

10.1038/s41375-024-02378-5

Cite this

Rodríguez-Arbolí, E., Othus, M., Freeman, S. D., Buccisano, F., Ngai, L. L., Thomas, I., Palmieri, R., Cloos, J., Johnson, S., Meddi, E., Russell, N. H., Venditti, A., Gradowska, P., Ossenkoppele, G. J., Löwenberg, B., & Walter, R. B. (2024). Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML). Leukemia, 38(10), 2266-2269. https://doi.org/10.1038/s41375-024-02378-5

@article{7e1c9c73d2fa483fa7bf8c6cecb574a3,

title = "Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)",

keywords = "Humans, Neoplasm, Residual/diagnosis, Leukemia, Myeloid, Acute/pathology, Flow Cytometry/methods, Prognosis, Middle Aged, Male, Female, Aged, Adult",

author = "Eduardo Rodr{\'i}guez-Arbol{\'i} and Megan Othus and Freeman, {Sylvie D.} and Francesco Buccisano and Ngai, {Lok Lam} and Ian Thomas and Raffaele Palmieri and Jacqueline Cloos and Sean Johnson and Elisa Meddi and Russell, {Nigel H.} and Adriano Venditti and Patrycja Gradowska and Ossenkoppele, {Gert J.} and Bob L{\"o}wenberg and Walter, {Roland B.}",

year = "2024",

month = oct,

doi = "10.1038/s41375-024-02378-5",

language = "English",

volume = "38",

pages = "2266--2269",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "10",

}

Rodríguez-Arbolí, E, Othus, M, Freeman, SD, Buccisano, F, Ngai, LL, Thomas, I, Palmieri, R, Cloos, J, Johnson, S, Meddi, E, Russell, NH, Venditti, A, Gradowska, P, Ossenkoppele, GJ, Löwenberg, B & Walter, RB 2024, 'Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)', Leukemia, vol. 38, no. 10, pp. 2266-2269. https://doi.org/10.1038/s41375-024-02378-5

TY - JOUR

T1 - Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)

AU - Rodríguez-Arbolí, Eduardo

AU - Othus, Megan

AU - Freeman, Sylvie D.

AU - Buccisano, Francesco

AU - Ngai, Lok Lam

AU - Thomas, Ian

AU - Palmieri, Raffaele

AU - Cloos, Jacqueline

AU - Johnson, Sean

AU - Meddi, Elisa

AU - Russell, Nigel H.

AU - Venditti, Adriano

AU - Gradowska, Patrycja

AU - Ossenkoppele, Gert J.

AU - Löwenberg, Bob

AU - Walter, Roland B.

PY - 2024/10

Y1 - 2024/10

KW - Humans

KW - Neoplasm, Residual/diagnosis

KW - Leukemia, Myeloid, Acute/pathology

KW - Flow Cytometry/methods

KW - Prognosis

KW - Middle Aged

KW - Male

KW - Female

KW - Aged

KW - Adult

U2 - 10.1038/s41375-024-02378-5

DO - 10.1038/s41375-024-02378-5

M3 - Letter

C2 - 39169114

SN - 0887-6924

VL - 38

SP - 2266

EP - 2269

JO - Leukemia

JF - Leukemia

IS - 10

ER -